1 documents found
Head: Попов Сергій Борисович. Opened research of phase 1В farmakokinetiki, farmakodinamiki and safety of glitseril tri-(4-fenilbutirata), which appoint peroralno both non-permanent, and twice in a day during seven successive days, explored with violations of function of liver, with a cirrhosis and control group..
National University of Pharmacy. № 0106U013026
1 documents found
Updated: 2026-03-26
